Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity

more+
less-

Hissey Kientz, LLP is concerned that despite a recent recall notice for the heart drug Digitek, the drug’s manufacturer has failed to provide any additional information on how long the heart medication was being improperly manufactured. According to a press release issued by the manufacturer, some Digitek tablets may have been manufactured at double their normal strength, meaning that patients could receive a double dose of the drug, leading to an overdose. A Digitek overdose could lead to severe side effects, including heart attack, stroke or death.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Consumer Protection Updates, Health Updates, Firm Marketing Updates, Personal Injury Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hissey Kientz LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »